39154 Federal Register / Vol. 65, No. 122 / Friday, June 23, 2000 / Notices

Contact Person: Mary Sue Krause,

Scientific Review Administrator, Division of

Extramural Activities, National Institute of

Mental Health, NIH, Neuroscience Center,

6001 Executive Blvd., Room 6138, Bethesda,

MD 20892–9606, 301–443–6470.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Institute of

Mental Health Special Emphasis Panel.

Date: July 21, 2000.

Time: 1:00 PM to 4:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Bethesda, MD 20892, (Telephone Conference

Call).

Contact Person: David I. Sommers,

Scientific Review Administrator, Division of

Extramural Activities, National Institute of

Mental Health, NIH, Neuroscience Center,

6001 Executive Blvd., Room 6144, MSC 9606,

Bethesda, MD 20892–9606, 301–443–6470.

Name of Committee: National Institute of

Mental Health Special Emphasis Panel.

Date: August 1, 2000.

Time: 11:00 AM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Chevy Chase Holiday Inn, 5520

Wisconsin Ave., Chevy Chase, MD 20815.

Contact Person: David I. Sommers,

Scientific Review Administrator, Division of

Extramural Activities, National Institute of

Mental Health, NIH, Neuroscience Center,

6001 Executive Blvd., Room 6144, MSC 9606,

Bethesda, MD 20892–9606, 301–443–6470.

Name of Committee: National Institute of

Mental Health Special Emphasis Panel.

Date: August 17, 2000.

Time: 5:00 PM t9 6:30 PM.

Agenda: To review and evaluate grant

applications.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Bethesda, MD 20892, (Telephone Conference

Call).

Contact Person: Robert H. Stretch,

Scientific Review Administrator, Division of

Extramural Activities, National Institute of

Mental Health, NIH, Neuroscience Center,

6001 Executive Blvd., Room 6150, MSC 9608,

Bethesda, MD 20892–9608, 301–443–4728.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.242, Mental Health Research

Grants; 93.281, Scientist Development

Award, Scientist Development Award for

Clinicians, and Research Scientist Award;

93.282, Mental Health National Research

Service Awards for Research Training,

National Institutes of Health, HHS)

Dated: June 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–15936 Filed 6–22–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: June 25, 2000.

Time: 7:00 PM to 8:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Gaithersburg Holiday Inn,

Gaithersburg, MD 20879.

Contact Person: Priscilla B. Chen, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4104,

MSC 7814, Bethesda, MD 20892, (301) 435–

1787.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: July 6–7, 2000.

Time: 8:30 AM to 4:00 PM.

Agenda: To review and evaluate grant

applications.

Place: River Inn, 924 25th Street, NW,

Washington, DC 20037.

Contact Person: Gloria B. Levin, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3166,

MSC 7848, Bethesda, MD 20892, (301) 435–

1017, leving@csr.nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: July 6–7, 2000.

Time: 8:30 AM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Georgetown Holiday Inn, 2101

Wisconsin Avenue, NW, Washington, DC

20007.

Contact Person: Karen Sirocco, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 3184,

MSC 7848, Bethesda, MD 20892, (301) 435–

0676.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: July 6–7, 2000.

Time: 8:30 AM to 3:00 PM.

Agenda: To review and evaluate grant

applications and/or proposals.

Place: Georgetown Holiday Inn, 2101

Wisconsin Avenue, NW, Washington, DC

20007.

Contact Person: Prabha L. Atreya, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5152,

MSC 7842, Bethesda, MD 20892, (301) 435–

8367.

Name of Committee: AIDS and Related

Research Integrated Review Group, AIDS and

Related Research 3.

Date: July 6, 2000.

Time: 8:30 AM to 6:30 PM.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Georgetown, 2101

Wisconsin Avenue, NW., Washington, DC

20007.

Contact Person: Bruce Maurer, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5222,

MSC 7852, Bethesda, MD 20892, (301) 435–

1168.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: July 6, 2000.

Time: 1:00 PM to 3:00 PM.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892 (Telephone Conference Call).

Contact Person: Eugene M. Zimmerman,

PhD, Scientific Review Administrator, Center

for Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4202,

MSC 7812, Bethesda, MD 20892, 301–435–

1220, zimmerng@csr.nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: July 7, 2000.

Time: 8:00 AM to 6:00 PM.

Agenda: To review and evaluate grant

applications.

Place: The Ritz-Carlton-Pentagon City,

1250 South Hayes Street, Arlington, VA

22202.

Contact Person: Jean D. Sipe, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, RM. 4106,

MSC 7814, Bethesda, MD 20892, 301/435–

1743, sipej@csr.nih.gov.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: July 7, 2000.

Time: 8:30 AM to 3:30 PM.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn Georgetown, 2101

Wisconsin Avenue, NW., Washington, DC

20007.

Contact Person: Bruce Maurer, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5102,

MSC 7852, Bethesda, MD 20892, (301) 435–

1168.

Federal Register / Vol. 65, No. 122 / Friday, June 23, 2000 / Notices 39155

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: July 7, 2000.

Time: 3:00 PM to 4:00 PM.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892 (Telephone Conference Call).

Contact Person: Philip Perkins, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4148,

MSC 7804, Bethesda, MD 20892, (301) 435–

1718.

(Catalogue of Federal Domestic Assistance

Program Nos 93.306, Comparative Medicine,

93.306; 93.333, Clinical Research, 93.333,

93.337, 93.393–93.396, 93.837–93.844,

93.846–93.878, 93.892, 93.893, National

Institutes of Health, HHS)

June 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–15937 Filed 6–22–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Office of the Director, National

Institutes of Health; Notice of Meeting

Pursuant to section 10(a) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the Peer

Review Oversight Group.

The meeting will be open to the

public, with attendance limited to space

available. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

Name of Committee: Peer Review

Oversight Group.

Date: July 10–11, 2000.

Time: July 10, 2000, 8:30 AM to 5:00 PM.

Agenda: The discussions will focus on

peer review-related issues including, the use

of lay reviewers, structured review,

preliminary data, modular grant applications,

conflict of interest, Federal reimbursement

for compliance costs, and the status of

activities related to the implementation of

recommendations in the Regulatory Burden

Report.

Place: National Institutes of Health,

Building 60, 9000 Rockville Pike, Bethesda,

MD 20892.

Contact Person: Barbara Nolte, Program

Analyst, Office of Extramural Research,

National Institutes of Health, 9000 Rockville

Pike, Building 1, Room 252, Bethesda, MD

20892, 301–402–1058.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.14, Intramural Research

Training Award; 93.187, Undergraduate

Scholarship Program for Individuals from

Disadvantaged Backgrounds; 93.22, Clinical

Research Loan Repayment Program for

Individuals from Disadvantaged

Backgrounds; 93.232, Loan Repayment

Program for Research Generally; 93.39,

Academic Research Enhancement Award;

93.936, NIH Acquired Immunodeficiency

Syndrome Research Loan Repayment

Program, National Institutes of Health, HHS)

Dated: June 19, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–15938 Filed 6–22–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Substance Abuse and Mental Health

Services Administration

Federal Drug Testing Custody and

Control Form

AGENCY: Substance Abuse and Mental

Health Services Administration, HHS.

ACTION: Notice of final form.

SUMMARY: The Substance Abuse and

Mental Health Services Administration

(SAMHSA) has revised the Federal Drug

Testing Custody and Control Form

(CCF). The current Federal CCF has a

July 31, 2000, expiration date. The

Office of Management and Budget

(OMB) has approved the use of the new

Federal CCF until June 30, 2003. OMB

approval of the new Federal CCF allows

Federal agencies and employers

regulated by the Department of

Transportation (DOT) to begin using the

new Federal CCF on August 1, 2000, for

their workplace drug testing programs.

EFFECTIVE DATE: August 1, 2000.

FOR FURTHER INFORMATION CONTACT:

Walter F. Vogl, Ph.D., Drug Testing

Section, Division of Workplace

Programs, CSAP, 5600 Fishers Lane,

Rockwall II, Suite 815, Rockville,

Maryland 20857, tel. (301) 443–6014,

fax (301) 443–3031, or email:

wvogl@samhsa.gov.

SUPPLEMENTARY INFORMATION:

Background

All urine specimens must be collected

using chain of custody procedures to

document the integrity and security of

the specimen from the time of collection

until receipt by the laboratory. To

ensure uniformity among all Federal

agency and federally regulated

workplace drug testing programs, the

use of an OMB approved Federal CCF is

required. Based on the experiences of

using the current Federal CCF for the

past several years, SAMHSA and DOT

initiated a joint effort to develop a new

Federal CCF that was easier to use and

more accurately reflected both the

collection process and how results were

reported by the drug testing laboratories.

This effort included scheduling two

public meetings attended by over 35

industry representatives who

recommended most of the changes to

the current Federal CCF. As a result of

these two meetings, SAMHSA

published a proposed revised Federal

CCF in a Federal Register notice (64 FR

61916) on November 15, 1999. A sample

of the proposed form was included in

that notice.

The first major proposed change was

to make the revised Federal CCF a sixpart form by eliminating the split

specimen copy. Since the split

specimen copy is used only when the

split specimen is tested (i.e., less than

approximately 5 percent of split

specimens are tested), it would be more

efficient to have the split specimen test

result reported on the original

laboratory copy (Copy 1). When the split

specimen is tested, the primary

laboratory would need to make a

photocopy of Copy 1 of the Federal CCF

and send it along with the split

specimen to the second laboratory.

Although this procedure requires the

primary laboratory to make a

photocopy, SAMHSA and DOT believe

the cost saving associated with not

including a separate split specimen

copy with each Federal CCF outweighs

the cost associated with the few times

that Copy 1 will need to be photocopied

by the primary laboratory. Additionally,

eliminating the split specimen copy will

help make any handwritten information

appear more legible on the later copies.

The second major proposed change

was to move the specimen bottle seal(s)/

label(s) from the right side of the form

to the bottom of Copy 1. This change

would permit overprinting information

on the form using standard width tractor

feed printers rather than requiring more

expensive wide carriage printers. In

addition, the storage and handling

requirements would be similar to other

documents since the overall size of the

new Federal CCF (including the tractor

feed strips) is essentially the same as a

standard sheet of paper.

The third major proposed change

involved simplifying the chain of

custody step by requiring the collector

to only sign the form once. SAMHSA

and DOT believe the current

requirement for the collector to sign the